Insomnia Disorder
📧 Sign up to get email alerts when something new happens for Insomnia Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Become Your Own SLEEPexpert: a Behavioral Treatment Program for Insomnia in Patients With Psychiatric Disorders [NA]
This clinical trial update notes the completion of a study evaluating a behavioral treatment program for insomnia in patients with psychiatr…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: The Efficacy and Safty of FMT in Patients With CID [Phase 1, Phase 2]
A Phase 1/2 clinical trial update assessing the efficacy and safety of fecal microbiota transplantation for chronic insomnia disorder, with …
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: The DigIT Trial: The Effectiveness and Implementation of a Coached Digital Insomnia Treatment Program in a Regional Healthcare System. [NA]
The DigIT Trial completed evaluating the effectiveness and implementation of a coached digital insomnia treatment program in a regional heal…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of daridorexant in participants with insomnia disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Neuropsychological Outcome After Cardiac Arrest
This is a completed clinical trial update evaluating neuropsychological outcomes after out-of-hospital cardiac arrest. It focuses on cogniti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Culturally Adapted iCBT for Arabic-speaking Refugee and Migrant Youth With Common Mental Health Problems [NA]
Completed study evaluating a culturally adapted internet-based cognitive behavioral therapy (iCBT) for Arabic-speaking refugee and migrant y…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Sleep Well 24 (SWELL24) Healthy Sleep-Wake Behaviors in Older Adults [NA]
The Sleep Well 24 (SWELL24) trial studied healthy sleep-wake behaviors in older adults with Insomnia Disorder. The study has completed, and …
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: DAO DEFICIENCY SCREENING AMONG PATIENTS WITH INSOMNIA SYMPTOMS
A completed clinical trial examined screening for diamine oxidase (DAO) deficiency among patients with insomnia symptoms. The study was spon…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Changed Serum Levels of Sirtuin1 and Sirtuin3 and Their Correlations With Sleep Quality and Cognitive Function in the Patients With Chronic Insomnia Disorder
This completed clinical trial examined how serum levels of SIRT1 and SIRT3 relate to sleep quality and cognitive function in patients with c…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant [Phase 3]
Phase 3 study of Seltorexant as adjunctive therapy to antidepressants for adults and elderly with major depressive disorder with insomnia sy…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder [Phase 2]
An early Phase 2 study of TS-142 for insomnia disorder has completed, according to the trial update; no results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: A Clinical Study of Theta Burst Stimulation (cTBS) in the Treatment of Insomnia Disorder Targeting the Dentate Nucleus of the Cerebellum [NA]
A completed clinical trial investigating theta burst stimulation targeting the dentate nucleus of the cerebellum for insomnia disorder.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder [Phase 2]
Phase 2 trial evaluating the safety and efficacy of YZJ-1139 in insomnia disorder has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Tele-Self CBTI Trial [NA]
The Tele-Self CBTI trial for Insomnia Disorder completed, and results were posted on 2024-09-24. Sponsored by the VA Office of Research and …
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Software-delivered CBT-I for Insomnia Disorder [NA]
Completed clinical trial evaluating software-delivered cognitive behavioral therapy for insomnia disorder conducted at Peking University Six…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Modified Suanzaoren Decoction Versus Eszopiclone for the Treatment of Chronic Insomnia Disorder [NA]
A completed clinical trial comparing Modified Suanzaoren Decoction with Eszopiclone for chronic insomnia disorder to evaluate comparative ef…
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder [Phase 1, Phase 2]
Clinical trial update for HS-10506 in Chinese participants with insomnia disorder spanning Phase 1b/II, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder [Phase 3]
Phase 3 clinical trial updating safety and efficacy for YZJ-1139 in insomnia disorder; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Cannabinol Use in Patients With Insomnia Disorder [Phase 1, Phase 2]
Phase 1/2 clinical trial update on cannabinol use for insomnia disorder is completed.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep [Phase 3]
Phase 3 trial evaluating the efficacy and safety of ACT-541468 (Daridorexant) in adults with insomnia disorder has completed with results po…
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder [Phase 3]
Phase 3 study assessing efficacy and safety of ACT-541468 (Daridorexant) in adults and elderly with insomnia disorder has completed with res…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep [Phase 3]
A Phase 3 trial evaluated the long-term safety and tolerability of ACT-541468 (daridorexant) in adults and elderly with insomnia disorder; t…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia [Phase 2, Phase 3]
A trial update comparing melatonin 3 mg and 5 mg to cognitive behavioral therapy for insomnia (CBT-I) in adults with Insomnia Disorder acros…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder. [Phase 2, Phase 3]
Clinical trial update for Biolab Zolpidem Orodispersible in multiple doses for maintenance insomnia disorder across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder [Phase 2]
Phase 2 trial evaluating ACT-541468 for efficacy and safety in elderly subjects with insomnia disorder has completed with posted results.